| Ident. | Authors (with country if any) | Title |
|---|
| 002D27 (2005) |
Alain Bottero [France] | L'éthique au secours de la psychochirurgie ? : Présence du corps |
| 002D29 (2005) |
J. Vignau [France] ; L. Karila [France] ; O. Costisella [France] ; V. Canva [France] | Hépatite C, interféron α et dépression : principales hypothèses physiopathologiques |
| 002D46 (2005) |
Isabelle Arnulf [France] ; Milagros Merino-Andreu [France] ; Frédéric Bloch [France] ; Eric Konofal [France] ; Marie Vidailhet [France] ; Valérie Cochen [France] ; Jean-Philippe Derenne [France] ; Yves Agid [France] | REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy |
| 002D60 (2005) |
M. Szczerbowska-Boruchowska [Pologne] ; J. Chwiej [Pologne] ; M. Lankosz [Pologne] ; D. Adamek [Pologne] ; S. Wojcik [Pologne] ; A. Krygowska-Wajs [Pologne] ; B. Tomik [Pologne] ; S. Bohic [France] ; J. Susini [France] ; A. Simionovici [France] ; P. Dumas [France] ; M. Kastyak [Pologne] | Intraneuronal investigations of organic components and trace elements with the use of synchrotron radiation |
| 002D80 (2005) |
M-P Perriol [France] ; K. Dujardin [France] ; P. Derambure [France] ; A. Marcq [France] ; J-L. Bourriez [France] ; E. Laureau [France] ; F. Pasquier [France] ; L. Defebvre [France] ; A. Destee [France] | Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease |
| 002F91 (2004) |
M. A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; P. Ravenscroft [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; M. J. Millan [France] ; J. M. Brotchie [Canada] | Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate |
| 002F92 (2004) |
Paula Ravenscroft [Royaume-Uni] ; Sylvie Chalon [France] ; Jonathan M. Brotchie [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] | Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia |
| 003029 (2004) |
N. Hamaue [Japon] ; M. Minami [Japon] ; M. Terado [Japon] ; M. Hirafuji [Japon] ; T. Endo [Japon] ; M. Machida [Japon] ; T. Hiroshige [Japon] ; A. Ogata [Japon] ; K. Tashiro [Japon] ; H. Saito [Japon] ; S. H. Parvez [France] | Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus |
| 003110 (2003) |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study |
| 003143 (2003) |
Julie Hudry [France] ; Ste Phane Thobois [France] ; Emmanuel Broussolle [France] ; Patrice Adeleine [France] ; Jean-Pierre Royet [France] | Evidence for Deficiencies in Perceptual and Semantic Olfactory Processesin Parkinson's Disease |
| 003197 (2003) |
Véronique Bonnaud [France] ; Virginie Audouin [France] ; Daniel Gaonac'H [France] ; Roger Gil [France] | La comparabilité des formes A et B du Trail Making Test: Les effets différentiels de la longueur du parcours et de la disposition spatiale des cibles chez différentes populations normales et pathologiques |
| 003220 (2003) |
Stéphane Thobois [France] ; Maria-Joao Ribeiro [France] ; Ebba Lohmann [France] ; Alexandra Dürr [France] ; Pierre Pollak [France] ; Olivier Rascol [France] ; Stéphane Guillouet [France] ; Elizabeth Chapoy [France] ; Nicolas Costes [France] ; Yves Agid [France] ; Philippe Remy [France] ; Alexis Brice [France] ; Emmanuel Broussolle [France] | Young-onset Parkinson disease with and without parkin gene mutations: A fluorodopa F 18 positron emission tomography study |
| 003228 (2003) |
R. Bordet [France] ; D. Devos [France] ; S. Brique [France] ; Y. Touitou [France] ; J. D. Guieu [France] ; C. Libersa [France] ; A. Destee [France] | Study of circadian melatonin secretion pattern at different stages of Parkinson's disease |
| 003230 (2003) |
Mireille Gony [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] | Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: A pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs |
| 003242 (2003) |
Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France] | Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole |
| 003262 (2003) |
Pierre Krystkowiak [France] ; Jean-Louis Blatt [France] ; Jean-Louis Bourriez [France] ; Alain Duhamel [France] ; Miriam Perina [France] ; Serge Blond [France] ; Jean-Daniel Guieu [France] ; Alain Destée [France] ; Luc Defebvre [France] | Effects of subthalamic nucleus stimulation and levodopa treatment on gait abnormalities in Parkinson disease |
| 003269 (2003) |
H. Mollion [France] ; J. Ventre-Dominey [France] ; P. F. Dominey [France] ; E. Broussolle [France] | Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease |
| 003271 (2003) |
C. Crevoisier [Suisse] ; A. Monreal [France] ; B. Metzger [France] ; T. Nilsen [Norvège] | Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy volunteers |
| 003339 (2002) |
P. H. Robert [France] ; S. Clairet [France] ; M. Benoit [France] ; J. Koutaich [France] ; C. Bertogliati [France] ; O. Tible [France] ; H. Caci [France] ; M. Borg [France] ; P. Brocker [France] ; P. Bedoucha [France] | The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment |
| 003346 (2002) |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation |
| 003438 (2002) |
P.-C. Nguimfack Mbodie [France] | La théorie de l'excitotoxicité du glutamate et l'implication potentielle des radicaux libres dans l'étiopathogénie de la schizophrénie apporte-t-elle un éclairage nouveau sur les liens entre : prédisposition génétique, facteurs environnementaux et biologie dans le déterminisme de ce trouble ? |
